Vivos Therapeutics Total Liabilities

Vivos Therapeutics (VVOS) currently reports a total liabilities of $26M as of March 2026. That compares with $6.9M in the prior-year period — up 282.7% year over year. Use the charts on this page to explore Vivos Therapeutics's total liabilities history and peer comparisons.

Vivos Therapeutics's total liabilities increased from $6.9M to $26M — a 282.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vivos Therapeutics reported $26M in total liabilities as of March 2026. That compares with $6.9M in the prior-year period — up 282.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vivos Therapeutics, and consider following VVOS for alerts when major investors trade the stock.

Vivos Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $26M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VVOS with unrelated industries.